Literature DB >> 17666887

The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1.

David A Stevenson1, David H Viskochil, Elizabeth K Schorry, Alvin H Crawford, Jacques D'Astous, Kathleen A Murray, J M Friedman, Linlea Armstrong, John C Carey.   

Abstract

Neurofibromatosis type 1 is diagnosed clinically based on the presence of two of seven criteria developed by a panel of experts in 1987. The sixth criterion focuses on skeletal findings and is as follows: "A distinctive osseous lesion such as sphenoid dysplasia or thinning of long bone cortex, with or without pseudarthrosis." The wording for this criterion is misleading. In particular, "thinning of long bone cortex" is not the characteristic radiographic presentation, and no mention of long bone bowing is included. The distinctive clinical feature of long bone dysplasia in neurofibromatosis type 1 is anterolateral bowing of the lower leg (portion of the body delimited by the knee and ankle). The usual radiographic findings of long bone dysplasia in neurofibromatosis type 1 at first presentation, prior to fracture, are anterolateral bowing with medullary canal narrowing and cortical thickening at the apex of the bowing. We suggest that anterolateral bowing of the lower leg, with or without fracture or pseudarthrosis, is a more appropriate description of the primary finding that a clinician will use to fulfill the sixth diagnostic criterion for neurofibromatosis type 1. Clarification of this diagnostic criterion is important for the clinician and for research protocols. Appropriate interpretation will improve understanding of the natural history and pathophysiology of neurofibromatosis type 1.

Entities:  

Mesh:

Year:  2007        PMID: 17666887      PMCID: PMC3244139          DOI: 10.1097/gim.0b013e3180986e05

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  23 in total

1.  Congenital pseudarthrosis of the tibia.

Authors:  H B BOYD; F P SAGE
Journal:  J Bone Joint Surg Am       Date:  1958-12       Impact factor: 5.284

2.  Delayed autogenous bone graft in the treatment of congenital pseudarthrosis.

Authors:  J R MOORE
Journal:  J Bone Joint Surg Am       Date:  1949-01       Impact factor: 5.284

3.  Congenital kyphoscoliosis of the tibia.

Authors:  J M Rathgeb; P L Ramsey; H R Cowell
Journal:  Clin Orthop Relat Res       Date:  1974       Impact factor: 4.176

4.  Congenital pseudarthrosis of the tibia. A review of the literature and 52 cases from the Mayo Clinic.

Authors:  R L Masserman; H A Peterson; A J Bianco
Journal:  Clin Orthop Relat Res       Date:  1974 Mar-Apr       Impact factor: 4.176

5.  Radiological classification of congenital pseudarthrosis of the tibia.

Authors:  K S Andersen
Journal:  Acta Orthop Scand       Date:  1973

6.  Congenital pseudarthrosis of the tibia.

Authors:  H A Sofield
Journal:  Clin Orthop Relat Res       Date:  1971-05       Impact factor: 4.176

Review 7.  Neurofibromatosis update.

Authors:  Alvin H Crawford; Elizabeth K Schorry
Journal:  J Pediatr Orthop       Date:  2006 May-Jun       Impact factor: 2.324

8.  Congenital pseudarthrosis of the leg. Late results.

Authors:  K S Andersen
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

9.  Congenital pseudarthrosis of the tibia.

Authors:  R T Morrissy; E J Riseborough; J E Hall
Journal:  J Bone Joint Surg Br       Date:  1981

10.  Congenital "pseudarthroses" of the tibia: treatment with pulsing electromagnetic fields.

Authors:  C A Bassett; N Caulo; J Kort
Journal:  Clin Orthop Relat Res       Date:  1981 Jan-Feb       Impact factor: 4.176

View more
  7 in total

Review 1.  Diagnosis and treatment of osteopenic fractures in children.

Authors:  Charles T Mehlman; Marcia A Shepherd; Carie S Norris; Jessica B McCourt
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

2.  Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography.

Authors:  David A Stevenson; David H Viskochil; John C Carey; Hillarie Slater; Mary Murray; Xiaoming Sheng; Jacques D'Astous; Heather Hanson; Elizabeth Schorry; Laurie J Moyer-Mileur
Journal:  Bone       Date:  2008-12-11       Impact factor: 4.398

3.  Analysis of radiographic characteristics of anterolateral bowing of the leg before fracture in neurofibromatosis type 1.

Authors:  David A Stevenson; John C Carey; David H Viskochil; Laurie J Moyer-Mileur; Hillarie Slater; Mary A Murray; Jacques L D'Astous; Kathleen A Murray
Journal:  J Pediatr Orthop       Date:  2009-06       Impact factor: 2.324

4.  Combined technique with hydroxyapatite coated intramedullary nails in treatment of anterolateral bowing of congenital pseudarthrosis of tibia.

Authors:  Dmitry Popkov; Arnold Popkov; Siniša Dučić; Mikan Lazović; Pierre Lascombes
Journal:  J Orthop       Date:  2019-11-12

Review 5.  Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.

Authors:  Hildegard Kehrer-Sawatzki; David N Cooper
Journal:  Hum Genet       Date:  2021-12-20       Impact factor: 4.132

6.  Ankle Swelling in Patients With Type 1 Neurofibromatosis: A Report of Two Cases With Rare Presentation of Common Genodermatosis.

Authors:  Irene N Thomas; Amutha Balasundaram; Joseph Jenson James; Nithya Priyadharshini Shanmugam
Journal:  Cureus       Date:  2022-09-08

7.  Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

Authors:  Eric Legius; Ludwine Messiaen; Pierre Wolkenstein; Patrice Pancza; Susan M Huson; D Gareth Evans; Scott R Plotkin; Robert A Avery; Yemima Berman; Jaishri Blakeley; Dusica Babovic-Vuksanovic; Karin Soares Cunha; Rosalie Ferner; Michael J Fisher; Jan M Friedman; David H Gutmann; Hildegard Kehrer-Sawatzki; Bruce R Korf; Victor-Felix Mautner; Sirkku Peltonen; Katherine A Rauen; Vincent Riccardi; Elizabeth Schorry; Anat Stemmer-Rachamimov; David A Stevenson; Gianluca Tadini; Nicole J Ullrich; David Viskochil; Katharina Wimmer; Kaleb Yohay
Journal:  Genet Med       Date:  2021-05-19       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.